Atherogenesis and thrombosis: mechanisms, pathogenesis, and therapeutic implications

L T Clark1

  • 1Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.

Insights

Coronary heart disease (CHD) is a leading cause of death, driven by coronary atherosclerosis. Understanding atheroma development and plaque rupture offers therapeutic targets for treatment and reversal.

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Medical Research

Background:

  • Coronary heart disease (CHD) remains a primary cause of mortality in the US, despite a significant decline in death rates.
  • Coronary atherosclerosis underlies CHD, involving a complex inflammatory and proliferative response to intimal injury.
  • Acute events like myocardial infarction are linked to atherosclerotic plaque rupture and thrombosis.

Purpose of the Study:

  • To elucidate the pathogenic mechanisms of coronary atherosclerosis progression.
  • To identify potential therapeutic strategies for managing and potentially reversing CHD.
  • To understand the factors contributing to acute coronary plaque instability.

Main Methods:

  • Review of the pathological processes involved in atheroma formation and progression.
  • Analysis of the sequence of cellular and molecular events following arterial injury.
  • Examination of the pathophysiology of plaque rupture and luminal thrombosis.

Main Results:

  • Superficial intimal injury initiates a cascade leading to obstructive atheroma development.
  • Chronic injury and repeated inflammatory cycles drive atheroma progression and arterial occlusion.
  • Plaque rupture, potentially due to hemodynamic stress on fragile caps, precipitates acute coronary syndromes.

Conclusions:

  • Therapeutic interventions targeting platelet aggregation, coagulation, and thrombosis are crucial.
  • The pathogenesis of atherosclerosis suggests possibilities for arresting and reversing the disease process.
  • Further research into plaque stability mechanisms is warranted to prevent acute cardiovascular events.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...